These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 17307006)

  • 1. Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients.
    Schollen E; Keldermans L; Foulquier F; Briones P; Chabas A; Sánchez-Valverde F; Adamowicz M; Pronicka E; Wevers R; Matthijs G
    Mol Genet Metab; 2007 Apr; 90(4):408-13. PubMed ID: 17307006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PMM2 intronic branch-site mutations in CDG-Ia.
    Vuillaumier-Barrot S; Le Bizec C; De Lonlay P; Madinier-Chappat N; Barnier A; Dupré T; Durand G; Seta N
    Mol Genet Metab; 2006 Apr; 87(4):337-40. PubMed ID: 16376131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping.
    Vuillaumier-Barrot S; Barnier A; Cuer M; Durand G; Grandchamp B; Seta N
    Hum Mutat; 1999 Dec; 14(6):543-4. PubMed ID: 10571956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PMM2 mutation spectrum, including 10 novel mutations, in a large CDG type 1A family material with a focus on Scandinavian families.
    Bjursell C; Erlandson A; Nordling M; Nilsson S; Wahlström J; Stibler H; Kristiansson B; Martinsson T
    Hum Mutat; 2000 Nov; 16(5):395-400. PubMed ID: 11058896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology.
    Aronica E; van Kempen AA; van der Heide M; Poll-The BT; van Slooten HJ; Troost D; Rozemuller-Kwakkel JM
    Acta Neuropathol; 2005 Apr; 109(4):433-42. PubMed ID: 15714316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts.
    Eklund EA; Merbouh N; Ichikawa M; Nishikawa A; Clima JM; Dorman JA; Norberg T; Freeze HH
    Glycobiology; 2005 Nov; 15(11):1084-93. PubMed ID: 16079417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of three splicing mutations identified in the PMM2 gene: toward a new therapy for congenital disorder of glycosylation type Ia.
    Vega AI; Pérez-Cerdá C; Desviat LR; Matthijs G; Ugarte M; Pérez B
    Hum Mutat; 2009 May; 30(5):795-803. PubMed ID: 19235233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).
    Matthijs G; Schollen E; Bjursell C; Erlandson A; Freeze H; Imtiaz F; Kjaergaard S; Martinsson T; Schwartz M; Seta N; Vuillaumier-Barrot S; Westphal V; Winchester B
    Hum Mutat; 2000 Nov; 16(5):386-94. PubMed ID: 11058895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.
    Quelhas D; Quental R; Vilarinho L; Amorim A; Azevedo L
    Ann Hum Genet; 2007 May; 71(Pt 3):348-53. PubMed ID: 17166182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations.
    Pérez-Dueñas B; García-Cazorla A; Pineda M; Poo P; Campistol J; Cusí V; Schollen E; Matthijs G; Grunewald S; Briones P; Pérez-Cerdá C; Artuch R; Vilaseca MA
    Eur J Paediatr Neurol; 2009 Sep; 13(5):444-51. PubMed ID: 18948042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia).
    Schollen E; Kjaergaard S; Legius E; Schwartz M; Matthijs G
    Eur J Hum Genet; 2000 May; 8(5):367-71. PubMed ID: 10854097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new insight into PMM2 mutations in the French population.
    Le Bizec C; Vuillaumier-Barrot S; Barnier A; Dupré T; Durand G; Seta N
    Hum Mutat; 2005 May; 25(5):504-5. PubMed ID: 15844218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital disorder of glycosylation type 1a: three siblings with a mild neurological phenotype.
    Coman D; McGill J; MacDonald R; Morris D; Klingberg S; Jaeken J; Appleton D
    J Clin Neurosci; 2007 Jul; 14(7):668-72. PubMed ID: 17451957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome).
    Matthijs G; Schollen E; Pardon E; Veiga-Da-Cunha M; Jaeken J; Cassiman JJ; Van Schaftingen E
    Nat Genet; 1997 May; 16(1):88-92. PubMed ID: 9140401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDG type Ia and congenital cytomegalovirus infection: two coexisting conditions.
    Jamroz E; Adamek D; Paprocka J; Adamowicz M; Marszał E; Wevers RA
    J Child Neurol; 2009 Jan; 24(1):13-8. PubMed ID: 19168813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased recurrence risk in congenital disorders of glycosylation type Ia (CDG-Ia) due to a transmission ratio distortion.
    Schollen E; Kjaergaard S; Martinsson T; Vuillaumier-Barrot S; Dunoe M; Keldermans L; Seta N; Matthijs G
    J Med Genet; 2004 Nov; 41(11):877-80. PubMed ID: 15520415
    [No Abstract]   [Full Text] [Related]  

  • 17. Detailed mapping of the phosphomannomutase 2 (PMM2) gene and mutation detection enable improved analysis for Scandinavian CDG type I families.
    Bjursell C; Wahlström J; Berg K; Stibler H; Kristiansson B; Matthijs G; Martinsson T
    Eur J Hum Genet; 1998; 6(6):603-11. PubMed ID: 9887379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PMM2-CDG: phenotype and genotype in four affected family members.
    Bortot B; Cosentini D; Faletra F; Biffi S; De Martino E; Carrozzi M; Severini GM
    Gene; 2013 Dec; 531(2):506-9. PubMed ID: 23988505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of homozygosity for predominant mutations in PMM2 in Danish patients with carbohydrate-deficient glycoprotein syndrome type 1.
    Kjaergaard S; Skovby F; Schwartz M
    Eur J Hum Genet; 1998; 6(4):331-6. PubMed ID: 9781039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.